Tuesday, November 03, 2015 8:34:32 AM
Elko, Nevada (FSCwire) - Lithium Corporation [OTCQB – LTUM] “the Company” is pleased to announce that it is arranging a non brokered private placement of up to 4,000,000 units for gross proceeds of $100,000. Each unit consists of (1) one Common Share at $0.025 and (1) one Common Share Purchase Warrant, exercisable at a price of $0.05 within 1 year of the closing of the financing, or $0.075 if exercised between the first and second anniversaries of the closing of the financing.
Proceeds of the financing are to be used for test work for material excavated during the trenching program at the BC Sugar Flake Graphite project, updating the 43-101 compliant report on its Fish Lake Valley Lithium Brine property, and for general and administrative purposes. Trenching at BC Sugar went very well with the Company better defining a zone of weathered graphitic gneiss approximately 30 meters, in width, with a higher grade core that is approximately 20 meters in width. Samples from the program have been sent to the laboratory, and the company is awaiting initial results before determining what further studies to conduct on the mineralized material extracted during the program.
The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, (the "Act") and may not be offered or sold in the United States absent registration or an applicable exemption from registration, under the Act. For further information with regard to Lithium Corporation, please contact Brian Goss, or Tom Lewis at (775) 410-2206 or via email at info@lithiumcorporation.com
Notice Regarding Forward-Looking Statements
This current report contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of minerals prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/lithium11032015.pdf
Source: Lithium Corp. (OTCQB:LTUM) http://www.lithiumcorporation.com/
Recent LTUM News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 07:56:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 04:18:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 09:29:24 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 02:16:13 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM